ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.662,38
0,08%
S&P 500
5.431,60
-0,04%
US Dollar vs BRL
5,3768
0,00%
Bitcoin
66.166,90
0,24%
Brent Oil
82,275
0,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Clearmind Medicine Inc (CMND)

  7. Clearmind Medicine Inc (CMND) Notícias

CMND Clearmind Medicine Inc

1,11
0,03 (2,78%)
14 Jun 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Clearmind Medicine Inc CMND NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,03 2,78% 1,11 19:19:29
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,10 1,0501 1,14 1,11 1,08
mais cotações »

Notícias Recentes

Data Hora Fonte Título
11/06/202408:44GLOBEClearmind Medicine Revolutionizes the $13 Billion..
10/05/202409:24GLOBEClearmind Medicine Advances its Proprietary Psychedelic-..
07/05/202408:46GLOBEClearmind Medicine Secures Exclusive Global Rights to..
30/04/202417:15GLOBEClearmind Applies to Cease Being a Reporting Issuer in..
17/04/202408:49GLOBEClearmind Medicine Announces Exclusive Licensing Agreement..
10/04/202408:17GLOBEClearmind Medicine Files U.S. Patent Application for..
09/04/202409:07GLOBEClearmind Medicine CEO Issues Letter to Shareholders
19/03/202408:55GLOBEBreakthrough in Wellness: Clearmind Medicine's Psychedelic..
13/03/202409:14GLOBEClearmind Medicine Obtains Clearance for its Psychedelic-..
13/03/202408:30GLOBEClearmind Medicine Received Approval for a Voluntary..
27/02/202409:58GLOBESciSparc-Clearmind Partnership Yields Three New..
23/02/202409:06GLOBEClearmind Medicine Receives Approval to Commence its Phase..
20/02/202409:14GLOBEClearmind Medicine Submits Three International Patent..
05/02/202409:51GLOBEClearmind Medicine Receives Patent Approval for its..
01/02/202410:15GLOBEClearmind Medicine Announces Exclusive, Long-Term Licensing..
16/01/202413:19GLOBEClearmind Medicine Inc. Closes US$2.4 Million Registered..
11/01/202411:28GLOBEClearmind Medicine Inc. Announces Pricing of $2.4 Million..
10/01/202409:18GLOBEClearmind Medicine Completed Type A Meeting with the FDA
04/01/202409:18GLOBEClearmind Medicine and SciSparc Reflect on Successful..
14/12/202310:26GLOBEClearmind Medicine Announces It Is In Compliance with All..
05/12/202310:47GLOBEClearmind Medicine Achieved Positive Results in Cocaine..
01/12/202310:14GLOBEWeight loss MEAI: Clearmind Medicine’s Novel Obesity Drug..
28/11/202310:25GLOBEClearmind Medicine Announces Positive Results from its..
27/11/202310:55GLOBEClearmind Medicine to Participate in Traditional vs. Novel..
21/11/202310:15GLOBEClearmind Medicine Announces 1-for-30 Reverse Share Split
17/11/202318:15GLOBEClearmind Medicine Announces Receipt of Nasdaq Delisting..
15/11/202309:37GLOBEClearmind Medicine Announces Shareholders Meeting Results
09/11/202311:20GLOBEClearmind Medicine to Pioneer Psychedelic Clinical Trials..
05/10/202310:00GLOBEClearmind Medicine to Present at the 8th Annual Dawson James..
21/09/202310:35GLOBEDawson James Securities Announces October Date for 8th..
18/09/202313:16GLOBEClearmind Medicine Closes US$2.25 Million Public Offering
14/09/202310:23GLOBEClearmind Medicine Announces Pricing of US$2.25 Million..
06/09/202310:20GLOBEClearmind Medicine Announces Clinical Research Collaboration..
14/08/202309:25GLOBEClearmind Medicine Announces Collaboration with CTS Ltd., a..
01/08/202310:00GLOBESciSparc and Clearmind Collaboration Continues to Increase..
17/07/202317:15GLOBEClearmind Medicine Announces Share-Based Payment for the..
11/07/202309:30GLOBEDr. Fatima Cody Stanford, Associate Professor of Medicine..
16/06/202310:05GLOBEClearmind Medicine and SciSparc to Conduct Study Evaluating..

Seu Histórico Recente

NASDAQ
CMND
Clearmind Medicine
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados